IP Verse

Probiotic Bacteria - EP2836223

The patent EP2836223 was granted to Skinbiotherapeutics on Mar 6, 2024. The application was originally filed on Mar 15, 2013 under application number EP13711111A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2836223

SKINBIOTHERAPEUTICS
Application Number
EP13711111A
Filing Date
Mar 15, 2013
Status
Patent Maintained As Amended
Feb 2, 2024
Grant Date
Mar 6, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CABINET BECKER ET ASSOCIESJan 28, 2022CABINET BECKER ET ASSOCIESADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP2161329
DESCRIPTIONUS4839281
DESCRIPTIONUS5032399
DESCRIPTIONUS5837238
DESCRIPTIONUS6872565
DESCRIPTIONUS7517681
DESCRIPTIONWO2006000992
DESCRIPTIONWO2010056198
DESCRIPTIONWO2011029784
DESCRIPTIONWO2011045471
EXAMINATIONFR2937547
EXAMINATIONWO2011029784
INTERNATIONAL-SEARCH-REPORTEP1609463
INTERNATIONAL-SEARCH-REPORTEP2206506
INTERNATIONAL-SEARCH-REPORTEP2332520
INTERNATIONAL-SEARCH-REPORTFR2889057
INTERNATIONAL-SEARCH-REPORTWO0113956
INTERNATIONAL-SEARCH-REPORTWO2006073430
INTERNATIONAL-SEARCH-REPORTWO2010013179
INTERNATIONAL-SEARCH-REPORTWO2010056198
OPPOSITIONUS2010086520
OPPOSITIONWO2009031099
OPPOSITIONWO2012152270

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Alhubail et al. (2017), 700 Lactobacillus rhamnosus.GG and its lysate protects human epidermal keratinocytes from the toxic effect of specific wound pathogens, Journal.of investigative Dermatology, 137, S313-
OPPOSITION- Anonymous, "Guidance for Industry Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice", (20040901), pages 1 - 59, URL: https://www.fda.gov/downloads/Drugs/Guidances/ucm070342.pdf, (20170718), XP055391797-
OPPOSITION- Anonymous, "Lactobacillus rhamnosus ATCC 53103", ATCC - Product Sheet, (20210101), ATCC - Product Sheet, (20220214), XP055891107-
OPPOSITION- El-Chami et al.(2022) Front..Microbiol. 13: 875542-
OPPOSITION- Mohammedsaeed et al. (2014) Applied and Environmental Microbiology, 80(18):5773-5781-
OPPOSITION- "Why is ATCC 2 Bacillus cereus no longer available on the ATCC website?", ATCC - FAQs, URL: https://www.atcc.org/support/technical-support/faqs/bacillus-cereus, XP055891109-
OPPOSITION- MOHAMMEDSAEED W. et al., "Probiotic lactobasilli", British Journal of Dermatology, (20120327), vol. 166, pages e37 - e38, XP071053111

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents